Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Humacyte, Inc. - Common Stock
(NQ:
HUMA
)
0.7100
+0.0374 (+5.56%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Humacyte, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
41 Stocks Moving In Monday's Mid-Day Session
↗
May 16, 2022
Gainers Data Storage Corporation (NASDAQ: DTST) shares jumped 51.1% to $3.4750 after the company reported better-than-expected Q1 financial results.
Via
Benzinga
Earnings Scheduled For May 13, 2022
↗
May 13, 2022
Companies Reporting Before The Bell • Codere Online Luxembourg (NASDAQ:CDRO) is estimated to report quarterly loss at $0.13 per share on revenue of $20.08 million.
Via
Benzinga
Humacyte Posts Preclinical Data Of Small-Diameter Human Acellular Vessel In Bypass Grafting
↗
January 28, 2022
Humacyte Inc (NASDAQ: HUMA) has announced
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
April 19, 2022
Gainers
Via
Benzinga
Humacyte's Return On Capital Employed Insights
↗
March 30, 2022
Pulled from Benzinga Pro data, Humacyte (NASDAQ:HUMA) posted Q4 earnings of $42.59 million, an increase from Q3 of 234.92%. Sales dropped to $177.00 thousand, a 26.56% decrease between quarters.
Via
Benzinga
The Daily Biotech Pulse: Sanofi-IGM Ink Antibody Drug Collaboration; NeoGenomics Sinks On CEO Departure, Q1 Warning; Decision Day For Akebia
↗
March 29, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
How To Attend Humacyte Q4 2021 Earnings Conference Call
↗
March 22, 2022
Humacyte (NASDAQ:HUMA) will host a conference call at 08:00 AM ET on March 29, 2022, to discuss Q4 2021 earnings results. How to Attend Humacyte (HUMA) Conference Call Follow this...
Via
Benzinga
Earnings Scheduled For March 29, 2022
↗
March 29, 2022
Companies Reporting Before The Bell • 36KR Holdings (NASDAQ:KRKR) is projected to report quarterly loss at $0.02 per share on revenue of $15.62 million.
Via
Benzinga
Humacyte's Human Acellular Vessel Shows Long Term Benefit In Hemodialysis Patients
↗
February 28, 2022
Humacyte Inc (NASDAQ: HUMA) announced five-year data from a Phase 2 trial of Human Acellular Vessel (HAV) for arteriovenous (AV) access in hemodialysis. In the...
Via
Benzinga
The Week Ahead In Biotech (March 27-April 2): Lipocine, Akebia, Merck Await FDA Verdicts, Adcom Test For Amylyx, BioNTech Earnings And More
↗
March 27, 2022
Biotech stocks reversed course in the week ending March 25, as an increase in risk appetite prompted traders to move money out of defensives and into risky bets.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 22, 2021
↗
September 22, 2021
Upgrades Argus Research upgraded the previous rating for Simon Property Group Inc (NYSE:
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
↗
January 05, 2022
Before 10 am on Wednesday, 99 companies set new 52-week lows. Facts of Interest About Today's 52-Week Lows: Sea (NYSE:SE) was the largest firm by market cap to set a...
Via
Benzinga
Stocks Hitting New 52-Week Lows Today
↗
January 03, 2022
On Monday morning, 60 companies achieved new lows for the year. Points of Interest From Today's 52-Week Lows And Highs: Ginkgo Bioworks Holdings (NYSE:DNA) was...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 16, 2021
↗
September 16, 2021
Upgrades For Signet Jewelers Ltd (NYSE:
Via
Benzinga
64 Biggest Movers From Yesterday
↗
November 02, 2021
Gainers ABVC BioPharma, Inc. (NASDAQ: ABVC) shares climbed 137.4% to close at $6.03 on Monday on abnormally-high volume. The stock is seeing increased interest by traders on...
Via
Benzinga
38 Stocks Moving In Wednesday's Mid-Day Session
↗
September 01, 2021
Gainers Focus Universal Inc. (NASDAQ: FCUV) shares jumped 108.2% to $10.62. The stock started trading on Nasdaq Capital Market yesterday. Sequential Brands Group, Inc. (NASDAQ:...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 29, 2021
↗
October 29, 2021
Upgrades For Preferred Bank (NASDAQ:
Via
Benzinga
After NASDAQ Debut, Humacyte's Investor Adds $25M Infusion
↗
August 31, 2021
Humacyte Inc (NASDAQ: HUMA), which merged with the special purpose acquisition company Alpha Healthcare Acquisition Corp last week, received an immediate...
Via
Benzinga
3 Stocks Insiders Are Buying
↗
August 30, 2021
When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 24, 2021
↗
September 24, 2021
Upgrades Berenberg upgraded the previous rating for Tenable Holdings Inc (NASDAQ:
Via
Benzinga
35 Stocks Moving In Friday's Mid-Day Session
↗
August 27, 2021
Gainers Support.com, Inc. (NASDAQ: SPRT) shares climbed 87% to $36.83 on abnormally high volume amid continued volatility. The stock has recently been mentioned as a potential...
Via
Benzinga
72 Biggest Movers From Yesterday
↗
September 14, 2021
Gainers aTyr Pharma, Inc. (NASDAQ: LIFE) jumped 67% to settle at $9.15 on Monday as the company announced positive results from its Phase 1b/2a trial evaluating its lead...
Via
Benzinga
53 Biggest Movers From Friday
↗
September 07, 2021
Gainers Innate Pharma S.A. (NASDAQ: IPHA) shares surged 47.1% to settle at $6.15 on Friday after SVB Leerink upgraded the stock from Market Perform to Outperform. Vera...
Via
Benzinga
The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab
↗
September 02, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 1) AbbVie Inc. (NASDAQ: ABBV...
Via
Benzinga
54 Biggest Movers From Yesterday
↗
September 02, 2021
Gainers Focus Universal Inc. (NASDAQ: FCUV) shares climbed 278% to close at $19.28 on Wednesday. The stock started trading on Nasdaq Capital Market yesterday. Sequential Brands...
Via
Benzinga
60 Biggest Movers From Friday
↗
August 30, 2021
Gainers Vinco Ventures, Inc. (NASDAQ: BBIG) shares rose 80.9% to close at $5.30 on Friday. The company recently reported a Q2 loss of $5.13 per share. Navios Maritime Acquisition...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
